| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |